Topics
.jpg%3Fwidth%3D300&w=3840&q=75)
bone marrowAnatomical structure
amyloidosisDisease
IgGDrug
proteinDisease
immunoglobulin GDrug
plasma cellAnatomical structure
IgADrug
Lymphoma-related amyloidosis is a rare entity. Systemic AL amyloidosis is generally caused by an underlying plasma cell clone in the bone marrow with an intact monoclonal immunoglobulin G (IgG) or IgA protein. The rarity of the lymphoma-related amyloidosis makes the generation of data in randomized trials and the determination of the optimal treatment almost impossible. Therefore, treatment recommendations discussed here are based on either retrospective or small prospective trials of single centers
International audienceUNLABELLED: DEFINITION OF THE DISEASE: AL amyloidosis results from extra-cellu...
Immunoglobulin light chain (AL) amyloidosis is a systemic disease in which different systems such as...
Primary systemic light chain amyloidosis or immunoglobulin light-chain amyloidosis (AL) is the most ...
Immunoglobulin light chain (AL) amyloidosis may be caused by a B-cell non-Hodgkin lymphoma (NHL) rat...
Immunoglobulin light chain amyloidosis can be either systemic or localized. Although these condition...
Purpose: Immunoglobulin M (IgM)–related light chain (AL) amyloidosis, which accounts for 6% to 10% ...
Immunoglobulin M (IgM)-related amyloidosis remains a rare and little-known complication of monoclona...
International audienceImmunoglobulin M (IgM)-related amyloidosis remains a rare and little-known com...
Monoclonal immunoglobulin M (IgM)-related light chain (AL) amyloidosis, which accounts for 5%–7% of ...
Background Systemic AL amyloidosis is a rare complication of immunoglobulin light chain secreting B ...
: The treatment of patients with systemic light chain (AL) amyloidosis is a challenge to hematologis...
Purpose: Immunoglobulin M (IgM)-related light chain (AL) amyloidosis, which accounts for 6% to 10% o...
IgM-associated AL amyloidosis is rare and may represent a distinct entity. Sixty (7%) of 868 consecu...
We report a patient with primary systemic AL amyloidosis who suffered from remarkable bilateral cerv...
International audienceUNLABELLED: DEFINITION OF THE DISEASE: AL amyloidosis results from extra-cellu...
Immunoglobulin light chain (AL) amyloidosis is a systemic disease in which different systems such as...
Primary systemic light chain amyloidosis or immunoglobulin light-chain amyloidosis (AL) is the most ...
Immunoglobulin light chain (AL) amyloidosis may be caused by a B-cell non-Hodgkin lymphoma (NHL) rat...
Immunoglobulin light chain amyloidosis can be either systemic or localized. Although these condition...
Purpose: Immunoglobulin M (IgM)–related light chain (AL) amyloidosis, which accounts for 6% to 10% ...
Immunoglobulin M (IgM)-related amyloidosis remains a rare and little-known complication of monoclona...
International audienceImmunoglobulin M (IgM)-related amyloidosis remains a rare and little-known com...
Monoclonal immunoglobulin M (IgM)-related light chain (AL) amyloidosis, which accounts for 5%–7% of ...
Background Systemic AL amyloidosis is a rare complication of immunoglobulin light chain secreting B ...
: The treatment of patients with systemic light chain (AL) amyloidosis is a challenge to hematologis...
Purpose: Immunoglobulin M (IgM)-related light chain (AL) amyloidosis, which accounts for 6% to 10% o...
IgM-associated AL amyloidosis is rare and may represent a distinct entity. Sixty (7%) of 868 consecu...
We report a patient with primary systemic AL amyloidosis who suffered from remarkable bilateral cerv...
International audienceUNLABELLED: DEFINITION OF THE DISEASE: AL amyloidosis results from extra-cellu...
Immunoglobulin light chain (AL) amyloidosis is a systemic disease in which different systems such as...
Primary systemic light chain amyloidosis or immunoglobulin light-chain amyloidosis (AL) is the most ...
Add to ORKG